New Insight on Survival for Patients with Head and Neck Cancers

	Tweet

In the U.S. this year more than 55,000 Americans will develop cancer of the head and neck and nearly 13,000 of them will die from it. If caught early, most of these cancers are highly treatable, but despite treatment, patients remain at risk for developing secondary malignancies.

A new study presented at the 2007 AAO-HNSF Annual Meeting & OTO EXPO revealed new insights into the onset and survival of patients who develop head and neck squamous cell carcinoma (HNSCC) after being treated for lymphoma.

The study evaluated the length of time it took patients being treated for lymphoma to develop a second cancer of the head and neck. It also compared two groups of cancer patients - one group who developed head and neck cancer as their first and only cancer and another group that developed head and neck cancer after being treated for lymphoma (Hodgkin’s lymphoma or non-Hodgkin’s lymphoma).

Findings showed that patients developing HNSCC as a second malignancy tended to develop it within six years of a lymphoma diagnosis. The study also indicated that individuals who developed head and neck cancer as a second cancer after being treated for non-Hodgkin’s lymphoma did not live as long as those who developed head and neck cancer after being treated for Hodgkin’s lymphoma. These results may lead to more affective counseling according to prognosis.

Title: Survival for Head and Neck Cancer after Lymphoma
Authors: Michael Moore, MD and Neil Bhattacharyya, MD
Date: Sunday, September 16, 10:32 am – 10:40 am

Information for the Media
The AAO-HNS Annual Meeting newsroom will be located in Registration East, Street Level of the Washington, DC Convention Center. Hours of operation: Saturday, September 15, 12 pm to 5 pm; Sunday - Tuesday, September 16 -18, 7:30 am to 5 pm; and Wednesday, September 19, 7:30 am to 2 pm. The newsroom serves as a work space for credentialed members of the media and credentialed public relations staff.

Source: American Academy of Otolaryngology Head and Neck Surgery (AAOHNS)

RELATED STORIES:
Brain Cancer Experts and Resources at Johns Hopkins   New procedure to make brain surgery safer   Physical activity in adolescence associated with decreased risk of brain cancer in adulthood   Rare Head and Neck Cancer Linked to HPV   Study finds 231 new genes associated with head and neck cancer   New robotic head and neck cancer surgery preserves speech, without scarring   Some brain tumors mimic the genetic program of germline cells   Customized Virus Kills Brain Tumor Stem Cells that Drive Lethal Cancer   Factors behind head and neck cancer revealed   Sex virus blamed for rise in head and neck cancers   Could smoking pot cut risk of head, neck cancer?   Celldex brain cancer vaccine doubles survival   Minimizing side effects from chemoradiation could help brain cancer patients live longer   HIV-positive head and neck cancer patients benefit from radiation therapy   Study Finds Promising Chemoradiation Therapy   Acrylamide not tied to thyroid, head-neck cancers   Radiotherapy Advance Builds Hope for Noninvasive Brain Cancer Treatment   IMRT improves outcomes in patients with extranodal lymphoma of the head and neck   News from Cancer: Disparities in head and neck cancer patients   Genetics of children’s brain tumour unlocked   HPV-Positive Tumor Status Indicates Better Survival in Patients with Oropharyngeal Cancer   Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]